Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques.

4区 医学 Q3 Medicine Contributions to nephrology Pub Date : 2023-01-01 Epub Date: 2023-06-01 DOI:10.1159/000527572
Patrick M Honore, Sydney Blackman, Ibrahim Bousbiat, Emily Perriëns, Rachid Attou
{"title":"Anticoagulation Prophylaxis in Extracorporeal Adsorption Techniques.","authors":"Patrick M Honore,&nbsp;Sydney Blackman,&nbsp;Ibrahim Bousbiat,&nbsp;Emily Perriëns,&nbsp;Rachid Attou","doi":"10.1159/000527572","DOIUrl":null,"url":null,"abstract":"<p><p>In this chapter, anticoagulation treatments for adsorption techniques in continuous renal replacement therapy (CKRT) will be reviewed. Anticoagulation used with adsorption techniques is quite different than anticoagulation in classical CKRT with nonadsorptive therapies. Regional citrate anticoagulation (RCA) and unfractionated heparin (UFH) are the most common anticoagulation modalities for both nonselective adsorptive membranes - such as surface-treated acrylonitrile 69 membranes (AN69ST) and polymethylmethacrylate membranes - and selective adsorptive membranes such as AN69-oXiris. For these techniques, the efficacy of RCA seems to be superior to UFH. Regardless of the lack of large comparative studies in comparison to ones conducted for adsorptive filter techniques in CKRT, RCA and UFH will also be discussed for nonselective adsorptive sorbents like CytoSorb and Jafron HA. For selective adsorptive sorbents, such as polymyxin-B hemoperfusion, UFH and RCA seems to be the appropriate techniques; however, randomized controlled trials confirming this are yet to be conducted. Lastly, anticoagulation prophylaxis for more specific techniques like coupled plasma filtration adsorption and double plasma molecular adsorption system will be discussed.</p>","PeriodicalId":10725,"journal":{"name":"Contributions to nephrology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Contributions to nephrology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000527572","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In this chapter, anticoagulation treatments for adsorption techniques in continuous renal replacement therapy (CKRT) will be reviewed. Anticoagulation used with adsorption techniques is quite different than anticoagulation in classical CKRT with nonadsorptive therapies. Regional citrate anticoagulation (RCA) and unfractionated heparin (UFH) are the most common anticoagulation modalities for both nonselective adsorptive membranes - such as surface-treated acrylonitrile 69 membranes (AN69ST) and polymethylmethacrylate membranes - and selective adsorptive membranes such as AN69-oXiris. For these techniques, the efficacy of RCA seems to be superior to UFH. Regardless of the lack of large comparative studies in comparison to ones conducted for adsorptive filter techniques in CKRT, RCA and UFH will also be discussed for nonselective adsorptive sorbents like CytoSorb and Jafron HA. For selective adsorptive sorbents, such as polymyxin-B hemoperfusion, UFH and RCA seems to be the appropriate techniques; however, randomized controlled trials confirming this are yet to be conducted. Lastly, anticoagulation prophylaxis for more specific techniques like coupled plasma filtration adsorption and double plasma molecular adsorption system will be discussed.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
体外吸附技术中的抗凝预防。
在本章中,将对连续性肾脏替代治疗(CKRT)中吸附技术的抗凝治疗进行综述。采用吸附技术的抗凝与采用非吸附疗法的经典CKRT中的抗凝截然不同。区域柠檬酸盐抗凝(RCA)和普通肝素(UFH)是非选择性吸附膜(如表面处理的丙烯腈69膜(AN69ST)和聚甲基丙烯酸甲酯膜)和选择性吸附膜如AN69oXiris最常见的抗凝方式。对于这些技术,RCA的疗效似乎优于UFH。尽管与CKRT中的吸附过滤技术相比缺乏大型比较研究,但也将讨论非选择性吸附吸附剂(如CytoSorb和Jafron HA)的RCA和UFH。对于选择性吸附吸附剂,如多粘菌素-B血液灌流,UFH和RCA似乎是合适的技术;然而,证实这一点的随机对照试验尚待进行。最后,将讨论更具体技术的抗凝预防,如偶联血浆过滤吸附和双血浆分子吸附系统。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Contributions to nephrology
Contributions to nephrology 医学-泌尿学与肾脏学
CiteScore
1.50
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
期刊介绍: The speed of developments in nephrology has been fueled by the promise that new findings may improve the care of patients suffering from renal disease. Participating in these rapid advances, this series has released an exceptional number of volumes that explore problems of immediate importance for clinical nephrology. Focus ranges from discussion of innovative treatment strategies to critical evaluations of investigative methodology. The value of regularly consolidating the newest findings and theories is enhanced through the inclusion of extensive bibliographies which make each volume a reference work deserving careful study.
期刊最新文献
Oxiris Membrane in Sepsis and Multiple Organ Failure. The Process of Adsorption and Cartridge Design. Introduction. Hemoperfusion in Trauma. Monitoring Treatment, Risks and Side Effects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1